|
|
Article: New Start-up Enavail Applies Proprietary Particle Engineering Technologies To Increase Drug Solubility, Stability and Bioavailability.
- Article from:
- Business Wire
- Article date:
- November 9, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Enavail to focus on the $80.2 Billion drug delivery market. Company's particle engineering technologies increase the bioavailability of poorly water-soluble drugs and stabilize proteinaceous compounds and peptides.
Visit the Enavail Booth #2612 at APPS Los Angeles
AUSTIN, Texas -- Particle engineering company Enavail announced today that it has obtained an exclusive license from The University of Texas at Austin for a portfolio of particle engineering technologies that will be utilized for pharmaceutical, biotechnology and nutraceutical applications. Enavail is an Emergent Technologies, Inc. (ETI) portfolio company, headed by Dr. Brian Windsor, President ...